Hubei Goto Biopharm Co.,Ltd. (SHE:300966)

Hubei Goto Biopharm Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	3,158	2,266	1,859	2,648	3,112	4,729
Market Cap Growth	85.59%	21.86%	-29.78%	-14.93%	-34.18%	-
Enterprise Value	4,481	3,527	2,838	3,321	3,500	4,781
Last Close Price	27.44	19.69	16.13	22.95	26.98	40.79
PE Ratio	-	-	-	115.10	77.42	60.37
PS Ratio	5.02	3.74	3.47	4.68	5.15	8.00
PB Ratio	3.47	2.49	1.83	2.59	3.17	5.71
P/TBV Ratio	4.07	2.93	2.13	2.94	3.52	6.07
P/OCF Ratio	45.17	55.22	-	38.86	-	81.52
EV/Sales Ratio	7.13	5.82	5.29	5.86	5.79	8.09
EV/EBITDA Ratio	42.57	43.12	100.45	62.18	50.18	55.11
EV/EBIT Ratio	-	-	-	123.29	77.00	74.15
Debt / Equity Ratio	1.45	1.43	1.12	0.77	0.79	0.20
Debt / EBITDA Ratio	12.36	15.88	39.68	14.25	10.60	1.84
Net Debt / Equity Ratio	1.36	1.33	0.98	0.59	0.32	-0.06
Net Debt / EBITDA Ratio	11.66	14.84	35.05	11.31	4.54	-0.56
Net Debt / FCF Ratio	-30.90	-9.68	-2.98	-1.77	-0.73	1.47
Asset Turnover	0.22	0.22	0.21	0.25	0.37	0.59
Inventory Turnover	1.18	1.22	1.12	1.09	1.16	1.56
Quick Ratio	0.37	0.34	0.44	0.61	1.26	1.37
Current Ratio	0.99	0.94	0.95	1.27	2.11	2.58
Return on Equity (ROE)	-8.30%	-8.49%	-3.11%	2.12%	4.37%	11.41%
Return on Assets (ROA)	-0.58%	-0.74%	-0.35%	0.74%	1.73%	4.00%
Return on Invested Capital (ROIC)	-1.26%	-1.63%	-0.81%	1.84%	4.38%	8.12%
Return on Capital Employed (ROCE)	-1.30%	-1.70%	-0.70%	1.50%	3.00%	7.30%
Earnings Yield	-2.26%	-3.24%	-1.48%	0.87%	1.29%	1.66%
FCF Yield	-1.27%	-5.53%	-17.87%	-12.88%	-13.88%	-0.70%
Dividend Yield	-	-	-	0.07%	-	0.33%
Payout Ratio	-	-	-	26.49%	66.92%	9.67%
Buyback Yield / Dilution	-1.58%	0.29%	0.05%	-0.13%	-8.77%	-22.87%
Total Shareholder Return	-1.58%	0.29%	0.05%	-0.06%	-8.77%	-22.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.